Navigation Links
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
Date:3/29/2008

he ARRIVE 1 and 2 registries, including those with long lesions, bifurcations, graft stenting, significant calcifications, and multi-vessel stenting. There were no differences in two-year safety rates (all death, Q-wave myocardial infarction (MI), or ARC definite/probable stent thrombosis) between ARRIVE simple-use patients and the clinical trial cohort. Adverse event rates at one year were expectedly higher for expanded-use versus simple-use ARRIVE patients, and included all death (4.2% vs. 2.3%, respectively), all MI (1.8% vs. 1.2%), target lesion revascularization (TLR) (6.2% vs. 3.4%), and ARC stent thrombosis (2.2% vs. 0.9%). However, TAXUS Stent-related adverse event rates during the second year of follow-up were lower for both expanded-use and simple-use patients than in the first year. Overall rates for TAXUS Stent- related events in ARRIVE were within expected ranges given the patient complexity.

Through two years, medically treated diabetic patients had a higher rate of all death (9.7% vs. 5.1%, p<0.0001) compared to non-diabetic patients but similar rates of TLR (8.1% vs. 7.7%, p=0.63), MI (2.5% vs. 2.2%, p=0.40), and ARC stent thrombosis (3.0% vs. 2.4%, p=0.13). Patients with graft stenting or stenting of bifurcation lesions had significantly higher rates of ARC stent thrombosis and TLR through two years, as expected given the complexity of the lesions treated.

"Our ARRIVE registry data provide valuable insights into the benefits of the TAXUS Stent in treating the broad spectrum of disease seen in real-world interventional practice," said Paul LaViolette, Chief Operating Officer at Boston Scientific. "The analysis reinforces data observed in our randomized clinical trials, showing positive long-term performance of the TAXUS Stent."

The safety and effectiveness of the TAXUS Express Stent has not been established in lesions longer than 28mm, bifurcations, saphenous vein grafts, multi-vessel stenting or diabetics.

Boston Scientif
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
2. New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
3. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
4. Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
5. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
6. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
7. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
8. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
9. Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007
10. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
11. Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... RESEARCH TRIANGLE PARK, N.C. , April 21, ... ) announced today that it will release its first ... April 28, 2015. United Therapeutics will host ... 9:00 a.m. Eastern Time.  The teleconference is accessible by ... of the teleconference will be available for one week ...
(Date:4/21/2015)... A leading manufacturer of stainless steel ... discuss its custom fabrication services today at INTERPHEX 2015. ... launched just prior to the INTERPHEX event. The expo ... and 23) at the Javits Center in New York ... largest and most innovative pharmaceutical and biotech firms will ...
(Date:4/20/2015)... Stent retriever thrombectomy, an endovascular technique ... brain reduced disability after stroke, according to a ... of the Society of Vascular and Interventional Neurology ... step forward that will change the way we ... Jovin, who is associate professor of Neurology and ...
(Date:4/20/2015)... WORTH, Texas , April 20, 2015 ... orthopedic surgeons for healing bone injuries. The orthobiologics market ... growth opportunities for its stakeholders. The global orthobiologics market ... and forecast of revenue. The global orthobiologics market was ... to reach $7,900.2 million by 2019, at a CAGR ...
Breaking Biology Technology:HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3
... (Nasdaq: ERES ) announced today that it will ... 2010 Tuesday, March 1, after the market closes. After the ... PM ET that day. For the conference ... United States or 1-412-858-4600 when calling internationally. There will be ...
... Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today ... BIO CEO & Investor Conference on Monday, February 14, ... the Waldorf=Astoria Hotel in New York City. Jack Lief, Arena,s President ... A live audio webcast of the presentation will be ...
... Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) ... its financial statements as of December 31, 2009 and 2010 ... "Top 25 Firms" by Inside Public Accounting , Marcum ... than 150 partners, in 23 offices throughout New York, New ...
Cached Biology Technology:ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011 2Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference 2Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference 3Stem Cell Assurance Announces Engagement of Marcum LLP as its Independent Auditors 2
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... Energy Secretary Steven Chu announced today that more than ... and Reinvestment Act will go toward scientific research, instrumentation, ... in six states will be receiving funds, along with ... "These new initiatives will help to create ...
... antibiotic drought, scientists in Massachusetts are describing successful use ... to discover badly needed new antibiotics. Their study appeared ... Frederick Ausubel and colleagues note in the ... involve adding the potential drug to cultures of bacteria ...
... the world,s environment ministers, government officials, diplomats and campaigners ... December 2009 to unite in the battle against climate ... the world has ever seen, the increasingly complex territory ... published today, 5 August, 2009, in IOP Publishing,s ...
Cached Biology News:Obama administration announces more than $327 million in Recovery Act funding for science research 2Obama administration announces more than $327 million in Recovery Act funding for science research 3Climate change poker: The barriers which are preventing a global agreement 2
...
... Ideal for relax positively and negatively supercoiled ... , Studying the effects of supercoiling ... reconstitution in vitro , Determining the degree ... Detecting mutant plasmids that differ in length by ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Immunogen: Synthetic peptide (KLH conjugated): L(506) S K S S S Q I R M S G L P A D N L A T(525) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: